Royalty Pharma PLC at Cowen Health Care Conference (Virtual) Transcript
Well, good morning, and welcome to the Royalty Pharma session at Cowen's 42nd Annual Health Care Conference. We're very pleased to have top management of Royalty Pharma here with us again this year. Representing the company is Marshall Urist, who is Executive Vice President and Co-head Research and [Investments] (corrected by company after the call) as well as joining us for Q&A, Terry Coyne, who is Executive Vice President and CFO.
Before I turn it to Marshall to show a few introductory slides, I just would like to note that we at Cowen view Royalty Pharma, as one of the most differentiated companies in biopharma given the fact that it is positioned to enjoy the promise of innovation, but we do believe with less risk. So interesting situation and to learn more about that, I will turn it to Marshall.
Thanks, Steve, and good morning to everyone. So we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |